Uterine Artery Embolization for the Treatment of Adenomyosis: Clinical Response and Evaluation with
article
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
Uterine artery embolization improved menorrhagia and quality of life in 12 of 15 patients, reducing uterine volume, fibroid volume, and junctional zone thickness.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE. This study was performed to evaluate the MR imaging appearance and clinical response of patients undergoing uterine artery embolization for the treatment of menorrhagia due to adenomyosis. MATERIALS AND METHODS. A retrospective review of 15 patients with adenomyosis and menorrhagia who underwent uterine artery embolization was performed. The diagnosis of adenomyosis was based on established MR imaging criteria. Clinical response was assessed at a minimum of 3 months after embolization. Follow-up MR imaging was performed 6 months after embolization. RESULTS. Of the 15 patients in this study, five had diffuse adenomyosis without evidence of uterine fibroids, one had focal adenomyosis without evidence of uterine fibroids, and the remaining nine had adenomyosis with one or more fibroids. At follow-up, 12 (92.3%) of the 13 patients reported significant improvement in presenting symptoms and quality of life. One patient continued experiencing menorrhagia, and one patient experienced amenorrhea during the 5 months of follow-up after embolization. MR imaging in nine patients, performed at a mean of 5.9 months after embolization, revealed significant reductions in median uterine volume (42%), median fibroid volume (71%), and mean‐junctional-zone thickness (11 mm; 33%; p < 0.5). Six of the nine patients had subendometrial regions of decreased T2 signal intensity after embolization. CONCLUSION. Uterine artery embolization is a promising nonsurgical alternative for patients with menorrhagia and adenomyosis. Significant improvement in presenting symptoms and in quality of life is associated with decreases in uterine size and junctional zone thickness. Larger prospective studies are needed to establish the safety and efficacy of this procedure for patients with adenomyosis.
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (28)
- A Clinical Failure of Uterine Fibroid Embolization due to Adenomyosis via openalex
- Adenomyosis: via openalex
- Adenomyosis and leiomyoma: differential diagnosis with MR imaging. via openalex
- Adenomyosis: a neglected diagnosis. via openalex
- Adenomyosis: A reappraisal of symptomatology via openalex
- Adenomyosis: current concepts and imaging considerations. via openalex
- Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation via openalex
- Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. via openalex
- Embolization for the Treatment of Adenomyosis via openalex
- Gray scale ultrasonography in the diagnosis of endometriosis and adenomyosis via openalex
- Morphometric evaluation of stromal vascularization in the endometrium in adenomyosis via openalex
- Uterine adenomyosis. A difficult sonographic diagnosis. via openalex
- Uterine Adenomyosis: Endovaginal US and MR Imaging Features with Histopathologic Correlation via openalex
- W2128937571 via openalex
- W2134068782 via openalex
- W2137329074 via openalex
- W2160302746 via openalex
- W2167978608 via openalex
- W1993382120 via openalex
- W1963929468 via openalex
- W2005368439 via openalex
- W2031388919 via openalex
- W1984528517 via openalex
- W2057502318 via openalex
- W2077702210 via openalex
- W2093448976 via openalex
- W2111007361 via openalex
- W2127396266 via openalex
Cited by (1)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK